New publication on the unmet medical need in MCT8 deficiency

Rare Thyroid Therapeutics announced today that the results of an international retrospective multicenter cohort study, looking at the disease characteristics and natural history of MCT8 deficiency has been published in the Lancet Diabetes & Endocrinology. The publication, which covers the most extensive cohort described to date with over 150 MCT8 deficient patients, outlines the significant morbidity in the condition and an increased mortality with a high prevalence of treatable underlying risk factors, underlining the unmet medical need and the need for effective therapies to treat the condition.

The full publication can be accessed [here] and the associated editorial [here].

Leave a Reply

Your email address will not be published. Required fields are marked *